A Phase II Study of Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Relapsed Non-Small Cell Lung Cancer.
Phase of Trial: Phase II
Latest Information Update: 01 Feb 2018
At a glance
- Drugs Vorinostat (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 05 May 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 Sep 2008 Status changed from completed to active, no longer recruiting, according to ClinicalTrials.gov.